Skip to content

Prostate Biopsies With Target Lesion on MRI

Prostate Biopsies With Target Lesion on MRI : When Can Non-targeted Biopsies be Dispensed With

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04692207
Enrollment
151
Registered
2020-12-31
Start date
2017-06-01
Completion date
2020-10-30
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Targeted prostate biopsy, Non-targeted prostate biopsy, MRI, prostate, biopsy

Brief summary

Our objective is to search for clinical, biological and imaging element that would better define the patient population that could benefit from targeted prostate biopsies only (from a cohort of patients who had targeted and non-targeted prostate biopsies).

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> or = at 18 years old * Prostatic MRI performed at the Montpellier University Hospital * Realization of targeted prostate biopsies (by fusion of MRI - ultrasound images) and non-targeted biopsies

Exclusion criteria

* Pre-biopsy MRI performed outside of the Montpellier University Hospital * MRI with artefacts * Not performing 12 non-targeted prostate biopsies

Design outcomes

Primary

MeasureTime frameDescription
Non-targeted biopsy not finding cancer of finding cancer of a grade lower than or egal to that found on targeted biopsies1 monthNon-targeted biopsy not finding cancer of finding cancer of a grade lower than or egal to that found on targeted biopsies

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026